Audent Global Asset Management LLC raised its position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 382.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 27,425 shares of the company's stock after purchasing an additional 21,742 shares during the quarter. DocuSign comprises 1.6% of Audent Global Asset Management LLC's portfolio, making the stock its 21st largest holding. Audent Global Asset Management LLC's holdings in DocuSign were worth $2,467,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FMR LLC boosted its stake in DocuSign by 178.2% during the 4th quarter. FMR LLC now owns 6,101,024 shares of the company's stock valued at $548,726,000 after purchasing an additional 3,908,139 shares in the last quarter. American Century Companies Inc. lifted its position in shares of DocuSign by 18.5% during the 4th quarter. American Century Companies Inc. now owns 5,315,459 shares of the company's stock valued at $478,072,000 after acquiring an additional 831,611 shares during the last quarter. Jericho Capital Asset Management L.P. lifted its position in shares of DocuSign by 34.0% during the 4th quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock valued at $427,642,000 after acquiring an additional 1,205,500 shares during the last quarter. Renaissance Technologies LLC lifted its position in shares of DocuSign by 4.9% during the 4th quarter. Renaissance Technologies LLC now owns 4,363,292 shares of the company's stock valued at $392,434,000 after acquiring an additional 205,304 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of DocuSign by 7.2% during the 4th quarter. Geode Capital Management LLC now owns 3,732,363 shares of the company's stock valued at $335,147,000 after acquiring an additional 249,179 shares during the last quarter. 77.64% of the stock is owned by institutional investors.
DocuSign Stock Performance
Shares of NASDAQ:DOCU traded up $2.04 during midday trading on Friday, hitting $87.75. 5,726,500 shares of the stock were exchanged, compared to its average volume of 2,783,615. DocuSign, Inc. has a 52-week low of $48.70 and a 52-week high of $107.86. The business's fifty day simple moving average is $81.62 and its two-hundred day simple moving average is $85.92. The company has a market capitalization of $17.77 billion, a PE ratio of 18.09, a P/E/G ratio of 6.94 and a beta of 1.21.
DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The business had revenue of $776.25 million during the quarter, compared to analyst estimates of $760.94 million. During the same period last year, the company earned $0.76 earnings per share. DocuSign's quarterly revenue was up 9.0% compared to the same quarter last year. As a group, equities analysts anticipate that DocuSign, Inc. will post 1.17 EPS for the current year.
Analysts Set New Price Targets
A number of brokerages have recently commented on DOCU. Citigroup increased their price objective on DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research report on Friday, March 14th. William Blair reiterated an "outperform" rating on shares of DocuSign in a research report on Monday, April 21st. Morgan Stanley cut their price objective on DocuSign from $97.00 to $92.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 16th. Needham & Company LLC reiterated a "hold" rating on shares of DocuSign in a research report on Thursday, April 17th. Finally, Hsbc Global Res upgraded DocuSign from a "moderate sell" rating to a "hold" rating in a report on Friday, April 11th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, DocuSign presently has a consensus rating of "Hold" and a consensus price target of $92.46.
Read Our Latest Research Report on DOCU
Insider Buying and Selling
In other DocuSign news, Director Teresa Briggs sold 534 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now directly owns 8,270 shares of the company's stock, valued at $722,880.70. This represents a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Blake Jeffrey Grayson sold 16,111 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $83.20, for a total transaction of $1,340,435.20. Following the transaction, the chief financial officer now directly owns 93,960 shares in the company, valued at $7,817,472. The trade was a 14.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 47,851 shares of company stock worth $3,912,239. Corporate insiders own 1.01% of the company's stock.
About DocuSign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also

Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report